Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome

被引：36

作者：

Ciccia, Francesco ^{[1
]}

Giardina, AnnaRita ^{[1
]}

Rizzo, Aroldo ^{[2
]}

Guggino, Giuliana ^{[1
]}

Cipriani, Paola ^{[3
]}

Carubbi, Francesco ^{[3
]}

Giacomelli, Roberto ^{[3
]}

Triolo, Giovanni ^{[1
]}

机构：

[1] Univ Palermo, Sez Reumatol, Dipartimento Biomed Med Interna & Specialist, I-90127 Palermo, Italy

[2] Azienda Osped Osped Riuniti Villa Sofia Cervello, Palermo, Italy

[3] Univ Aquila, Sez Reumatol, Dipartimento Sci Clin Applicate & Biotecnol, I-67100 Laquila, Italy

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷 / 05期

关键词：

CELL LYMPHOMA; DISEASES;

D O I：

10.1136/annrheumdis-2012-202754

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：782 / 783

页数：2

共 9 条

[1]

Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma [J].

Bard, J. Dien ;

Gelebart, P. ;

Anand, M. ;

Amin, H. M. ;

Lai, R. .

LEUKEMIA, 2008, 22 (08) :1595-1603

[2]

Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome [J].

Ciccia, Francesco ;

Guggino, Giuliana ;

Rizzo, Aroldo ;

Ferrante, Angelo ;

Raimondo, Stefania ;

Giardina, AnnaRita ;

Dieli, Francesco ;

Campisi, Giuseppina ;

Alessandro, Riccardo ;

Triolo, Giovanni .

ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (02) :295-301

[3]

Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma [J].

Dias, Catarina ;

Isenberg, David A. .

NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (06) :360-368

[4]

Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma [J].

Gelebart, Pascal ;

Zak, Zoulika ;

Dien-Bard, Jennifer ;

Anand, Mona ;

Lai, Raymond .

TRANSLATIONAL ONCOLOGY, 2011, 4 (01) :9-19

[5]

Maloney DG, 2012, NEW ENGL J MED, V366, P2008, DOI 10.1056/NEJMct1114348

[6]

Effectiveness of Rituximab Treatment in Primary Sjogren's Syndrome A Randomized, Double-Blind, Placebo-Controlled Trial [J].

Meijer, J. M. ;

Meiners, P. M. ;

Vissink, A. ;

Spijkervet, F. K. L. ;

Abdulahad, W. ;

Kamminga, N. ;

Brouwer, E. ;

Kallenberg, C. G. M. ;

Bootsma, H. .

ARTHRITIS AND RHEUMATISM, 2010, 62 (04) :960-968

[7]

B-cell targeted therapies in human autoimmune diseases: an updated perspective [J].

Townsend, Michael J. ;

Monroe, John G. ;

Chan, Andrew C. .

IMMUNOLOGICAL REVIEWS, 2010, 237 :264-283

[8]

The Anti-CD20 Antibody Rituximab Reduces the Th17 Cell Response [J].

van de Veerdonk, Frank L. ;

Lauwerys, Bernard ;

Marijnissen, Renoud J. ;

Timmermans, Kim ;

Di Padova, Franco ;

Koenders, Marije I. ;

Gutierrez-Roelens, Ilse ;

Durez, Patrick ;

Netea, Mihai G. ;

van der Meer, Jos W. M. ;

van den Berg, Wim B. ;

Joosten, Leo A. B. .

ARTHRITIS AND RHEUMATISM, 2011, 63 (06) :1507-1516

[9]

Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group [J].

Vitali, C ;

Bombardieri, S ;

Jonsson, R ;

Moutsopoulos, HM ;

Alexander, EL ;

Carsons, SE ;

Daniels, TE ;

Fox, PC ;

Fox, RI ;

Kassan, SS ;

Pillemer, SR ;

Talal, N ;

Weisman, MH .

ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (06) :554-558

← 1 →